EP 3782642 A4 20220413 - STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND IMMUNOGENIC CONJUGATE THEREOF
Title (en)
STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND IMMUNOGENIC CONJUGATE THEREOF
Title (de)
KAPSEL-POLYSACCHARIDE AUS STREPTOCOCCUS PNEUMONIAE UND KONJUGATE DAVON
Title (fr)
POLYSACCHARIDES CAPSULAIRES DE STREPTOCOCCUS PNEUMONIAE ET CONJUGUÉS IMMUNOGÈNES DE CEUX-CI
Publication
Application
Priority
- KR 20180045245 A 20180418
- KR 20180045246 A 20180418
- KR 20180045247 A 20180418
- KR 20180045248 A 20180418
- KR 2019004717 W 20190418
Abstract (en)
[origin: EP3782642A1] The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.
IPC 8 full level
A61K 39/09 (2006.01); A61K 39/00 (2006.01); A61P 31/00 (2006.01); A61P 31/04 (2006.01); A61P 37/04 (2006.01); C07K 14/315 (2006.01)
CPC (source: EP KR US)
A61K 39/092 (2013.01 - EP KR US); A61K 47/61 (2017.08 - US); A61P 31/00 (2018.01 - KR); A61P 31/04 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/315 (2013.01 - US); C07K 14/3156 (2013.01 - EP KR); A61K 2039/6031 (2013.01 - KR); A61K 2039/6037 (2013.01 - EP)
Citation (search report)
- [XI] WO 2018064444 A1 20180405 - BIOLOGICAL E LTD [IN], et al
- [XI] WO 2018027123 A1 20180208 - SANOFI PASTEUR INC [US], et al
- [XI] CN 103656631 B 20150819
- [Y] ANDERSON P ET AL: "Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 21, no. 13-14, 28 March 2003 (2003-03-28), pages 1554 - 1559, XP004412495, ISSN: 0264-410X, DOI: 10.1016/S0264-410X(02)00675-8
- [Y] WUORIMAA T ET AL: "TOLERABILITY AND IMMUNOGENICITY OF AN ELEVEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY TODDLERS", THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 20, no. 3, 1 March 2001 (2001-03-01), pages 272 - 277, XP009015483, ISSN: 0891-3668, DOI: 10.1097/00006454-200103000-00011
- See also references of WO 2019203599A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3782642 A1 20210224; EP 3782642 A4 20220413; AU 2019256218 A1 20201203; BR 112020021296 A2 20210126; CA 3096358 A1 20191024; CN 111989114 A 20201124; JP 2021522213 A 20210830; KR 20190121713 A 20191028; TW 202011985 A 20200401; US 11951162 B2 20240409; US 2021154287 A1 20210527; US 2024207384 A1 20240627; WO 2019203599 A1 20191024
DOCDB simple family (application)
EP 19788873 A 20190418; AU 2019256218 A 20190418; BR 112020021296 A 20190418; CA 3096358 A 20190418; CN 201980026186 A 20190418; JP 2020558479 A 20190418; KR 20190045589 A 20190418; KR 2019004717 W 20190418; TW 108113678 A 20190418; US 201917047563 A 20190418; US 202418598439 A 20240307